NCT02751177View on ClinicalTrials.gov

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer

NACompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

March 25, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

May 30, 2017

Conditions
Colorectal Cancer Metastatic
Interventions
GENETIC

KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA

Mutation in plasma DNA vs tumor tissue

Trial Locations (11)

21079

Centre Georges François Leclerc Dijon, Dijon

25020

CH Besançon-Hopital Jean Minjoz, Besançon

51092

CHU Reims-Hôpital Robert Debré, Reims

51100

Polyclinique Courlancy Reims, Reims

54000

Polyclinique de Gentilly, Nancy

54045

Hopital Belle-Isle-Metz, Metz

54500

CHRU Nancy, Vandœuvre-lès-Nancy

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

67065

Centre Paul Stauss, Strasbourg

89000

CH Auxerre, Auxerre

71 321

CH Chalon Sur Saône-William Morey, Chalon-sur-Saône

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02751177 - Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter